US 10632114
Pyruvate kinase activators for use in therapy
granted A61KA61K31/415A61K31/4406
Quick answer
US patent 10632114 (Pyruvate kinase activators for use in therapy) held by Agios Pharmaceuticals, Inc. expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/415, A61K31/4406, A61K31/47, A61K31/496